Skip to main content

Braidwell LP

SEC CIK
0001920938
Latest filing
Aug 14, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Braidwell LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q3 2023)
0
Sold out in Q3 2023
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q4 2022
Holdings of CRNX by Braidwell LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20230$00.0%−650,312−100.0%Sold outHolders
Q2 2023650,312$11.7M0.4%−1,369,402−67.8%ReducedHolders
Q1 20232,019,714$32.4M1.1%−1,449,960−41.8%ReducedHolders
Q4 20223,469,674$63.5M2.1%–No prior filingHolders